elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - enfermedad de fabry - otros tracto alimentario y metabolismo de los productos, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
nicotinell cool mint 2 mg chicle medicamentoso
haleon spain s.a. - nicotina - chicle medicamentoso - 2 mg - nicotina 2 mg - nicotina
nicotinell cool mint 4 mg chicle medicamentoso
haleon spain s.a. - nicotina - chicle medicamentoso - 4 mg - nicotina 4 mg - nicotina
nicotinell fruit 2 mg chicle medicamentoso
haleon spain s.a. - nicotina - chicle medicamentoso - 2 mg - nicotina 2 mg - nicotina
nicotinell fruit 4 mg chicle medicamentoso
haleon spain s.a. - nicotina - chicle medicamentoso - 4 mg - nicotina 4 mg - nicotina
nicotinell 2 mg chicle medicamentoso
glaxosmithkline consumer healthcare, s.a. - nicotina - chicle medicamentoso - 2 mg - nicotina 2 mg - nicotina
nicotinell 4 mg chicle medicamentoso
novartis consumer health s.a. - nicotina - chicle medicamentoso - 4 mg - nicotina 4 mg - nicotina
nicotinell mint 2 mg comprimidos para chupar
haleon spain s.a. - nicotina bitartrato dihidrato - comprimido para chupar - 2 mg - nicotina bitartrato dihidrato 2 mg - nicotina
nicotinell 7 mg/24 horas parche transdermicos
haleon spain s.a. - nicotina - parche transdÉrmico - 7 mg/24 h - nicotina 7 mg/24 h - nicotina